Quest Diagnostics (DGX) Stock Analysis
This is a peer-relative look at Quest Diagnostics (DGX): its performance, risk, profitability, growth, financial strength, dividend, and valuation are each measured against its Health Care Equipment & Services peers, so every number reads in context rather than in isolation.
Company Profile
| Profile Item | DGX |
|---|---|
| Name | Quest Diagnostics Incorporated |
| Country/Region | United States |
| GICS Sector | Health Care |
| GICS Industry Group | Health Care Equipment & Services |
| GICS Industry | Health Care Providers & Services |
| GICS Sub-Industry | Health Care Services |
| Market Capitalization | 28.21 billion USD |
| Currency | USD |
| Exchange | NYSE |
| Listing Date | December 17, 1996 |
| Security Type | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | Current stock: DGX | Industry group median |
|---|---|---|
| Total Return (1Y) | 45.88% | 21.53% |
| Total Return (3Y, Annualized) | 27.45% | 9.81% |
| Total Return (5Y, Annualized) | 14.84% | -2.76% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | Current stock: DGX | Industry group median |
|---|---|---|
| Volatility (1Y, Annualized) | 24.06% | 50.93% |
| Beta (5Y) | 0.54 | 0.85 |
| Max Drawdown (5Y) | -28.62% | -70.34% |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | Current stock: DGX | Industry group median |
|---|---|---|
| Sharpe Ratio (1Y) | 1.73 | 0.34 |
| Sortino Ratio (1Y) | 3.16 | 0.54 |
Profitability
ROE (TTM)
Quest Diagnostics (DGX) posts ROE of 15.32%, in the upper peer quartile. That suggests the company earns more from each dollar of shareholders’ equity than most industry peers, a useful capital-efficiency signal.
DGX
Health Care Equipment & Services industry group
15.32%
Group distribution
- Max
- 47.61%
- DGX
- 15.32%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Largest peers
- ISRG
- 17.93%
- SYK
- 16.02%
- UNH
- 15.77%
- DGX
- 15.32%
- MDT
- 10.65%
- ABT
- 9.14%
- MCK
- --
Net Margin (TTM)
Quest Diagnostics (DGX) keeps 9.54% of revenue as net profit, putting net margin in the upper peer quartile. After operating costs, interest, and taxes, more of each sales dollar reaches shareholders than it does at most industry peers.
DGX
Health Care Equipment & Services industry group
9.54%
Group distribution
- Max
- 29.35%
- DGX
- 9.54%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Largest peers
- ISRG
- 25.54%
- MDT
- 13.93%
- SYK
- 13.78%
- ABT
- 9.75%
- DGX
- 9.54%
- UNH
- 3.53%
- MCK
- 1.12%
Operating Margin (TTM)
Quest Diagnostics (DGX) turns 15.63% of revenue into operating profit, putting operating margin in the upper peer quartile. Before financing and taxes enter the picture, the day-to-day business keeps more of each sales dollar than most industry peers.
DGX
Health Care Equipment & Services industry group
15.63%
Group distribution
- Max
- 35.43%
- DGX
- 15.63%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Largest peers
- ISRG
- 33.29%
- SYK
- 22.96%
- MDT
- 19.33%
- DGX
- 15.63%
- ABT
- 11.66%
- UNH
- 5.82%
- MCK
- 1.48%
Profitability Metrics
| Metric | Current stock: DGX | Industry group median |
|---|---|---|
| ROE (TTM) | 15.32% | 5.45% |
| ROA (TTM) | 6.61% | 3.17% |
| Net Margin (TTM) | 9.54% | 2.18% |
| Operating Margin (TTM) | 15.63% | 6.81% |
| Gross Margin (TTM) | 33.18% | 55.21% |
Growth
Revenue Growth
Quest Diagnostics (DGX) grew revenue 11.78%, roughly around the peer group's normal range. Top-line momentum looks broadly typical for the industry.
EPS Growth
Quest Diagnostics (DGX) grew earnings per share 13.78%, roughly around the peer group's normal range. Bottom-line momentum looks broadly typical for the industry.
Growth Metrics
| Metric | Current stock: DGX | Industry group median |
|---|---|---|
| Revenue Growth (YoY) | 11.78% | 11.55% |
| Revenue Growth (3Y CAGR) | 3.74% | 10.83% |
| EPS Growth (YoY) | 13.78% | 4.88% |
| EPS Growth (3Y CAGR) | 3.16% | 14.59% |
Financial Strength
Current Ratio (MRQ)
Quest Diagnostics (DGX) has current ratio of 1.70, in the healthier middle range for its industry. The short-term asset cushion looks balanced relative to peers rather than stretched thin.
DGX
Health Care Equipment & Services industry group
1.70
Group distribution
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- DGX
- 1.70
- Q1
- 1.37
- Min
- 0.30
Largest peers
- ISRG
- 3.33
- SYK
- 2.18
- MDT
- 2.07
- DGX
- 1.70
- ABT
- 1.46
- MCK
- 0.90
- UNH
- 0.74
Debt / Equity (MRQ)
Quest Diagnostics (DGX) has debt-to-equity ratio of 0.80, roughly in line with the peer group’s normal leverage range. Its mix of debt and equity looks typical for the industry.
DGX
Health Care Equipment & Services industry group
0.80
Group distribution
- Max
- 1.88
- Q3
- 0.91
- DGX
- 0.80
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
Largest peers
- DGX
- 0.80
- UNH
- 0.70
- SYK
- 0.66
- ABT
- 0.61
- MDT
- 0.55
- ISRG
- --
- MCK
- --
Financial Strength Metrics
| Metric | Current stock: DGX | Industry group median |
|---|---|---|
| Current Ratio (MRQ) | 1.70 | 1.98 |
| Debt / Equity (MRQ) | 0.80 | 0.58 |
| Net Debt / EBITDA | 2.38 | 2.04 |
Dividends
Dividend Yield (TTM)
Quest Diagnostics (DGX) has dividend yield of 1.33%, above the entire industry range. That headline income is large, but yields this far above peers often come from a falling share price or an at-risk payout, so dividend safety matters more than the percentage itself.
DGX
Health Care Equipment & Services industry group
1.33%
Group distribution
- DGX
- 1.33%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Largest peers
- MDT
- 2.72%
- UNH
- 2.29%
- ABT
- 2.22%
- DGX
- 1.33%
- SYK
- 1.05%
- MCK
- 0.32%
- ISRG
- 0.00%
Dividend Payout Ratio (TTM)
Quest Diagnostics (DGX) has payout ratio of 25.10%, above the peer distribution for its industry. The dividend consumes more reported earnings than peers normally do, leaving unusually thin earnings cover.
DGX
Health Care Equipment & Services industry group
25.10%
Group distribution
- DGX
- 25.10%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Largest peers
- ABT
- 92.54%
- MDT
- 70.02%
- UNH
- 51.71%
- SYK
- 37.49%
- DGX
- 25.10%
- MCK
- 8.77%
- ISRG
- 0.00%
Dividend Metrics
| Metric | Current stock: DGX | Industry group median |
|---|---|---|
| Dividend Yield (TTM) | 1.33% | 0.00% |
| Dividend Payout Ratio (TTM) | 25.10% | 0.00% |
Valuation
P/E Ratio (TTM)
Quest Diagnostics (DGX) trades at P/E ratio of 25.46, near the industry’s usual earnings multiple. The stock is not showing a clear peer discount or premium on trailing earnings.
DGX
Health Care Equipment & Services industry group
25.46
Group distribution
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- DGX
- 25.46
- Q1
- 21.19
- Min
- 4.21
Largest peers
- ISRG
- 54.75
- ABT
- 41.02
- SYK
- 34.70
- MCK
- 27.36
- DGX
- 25.46
- MDT
- 25.01
- UNH
- 22.50
P/S Ratio (TTM)
Quest Diagnostics (DGX) trades at 2.38 on P/S ratio, roughly in the peer group’s normal range. The market is not making a strong cheap-or-rich statement about its revenue base.
DGX
Health Care Equipment & Services industry group
2.38
Group distribution
- Max
- 8.80
- Q3
- 4.32
- DGX
- 2.38
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
Largest peers
- ISRG
- 13.82
- SYK
- 4.72
- ABT
- 3.95
- MDT
- 3.47
- DGX
- 2.38
- UNH
- 0.78
- MCK
- 0.29
P/B Ratio (MRQ)
Quest Diagnostics (DGX) trades at 3.68 on P/B ratio, roughly in line with the industry’s normal price-to-book range. Its balance sheet is not being priced at a clear discount or premium versus peers.
DGX
Health Care Equipment & Services industry group
3.68
Group distribution
- Max
- 11.68
- Q3
- 6.12
- DGX
- 3.68
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Largest peers
- ISRG
- 9.82
- SYK
- 5.29
- ABT
- 3.73
- DGX
- 3.68
- UNH
- 3.60
- MDT
- 2.59
- MCK
- -30.85
Valuation Metrics
| Metric | Current stock: DGX | Industry group median |
|---|---|---|
| P/E Ratio (TTM) | 25.46 | 29.93 |
| P/S Ratio (TTM) | 2.38 | 2.13 |
| P/B Ratio (MRQ) | 3.68 | 3.00 |
| Free Cash Flow Yield (TTM) | 3.09% | 3.50% |